This compound is a sodium salt form of a difluoromethoxy-substituted heterocyclic sulfoxide. It is primarily used as an active pharmaceutical ingredient in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Pantoprazole sodium hydrate
pharmaceutical raw material
Ibandronate sodium
pharmaceutical raw material
Brinzolamide
pharmaceutical raw material
(2S,3S,4S,5R,6S)-6-[3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
pharmaceutical raw material
Ibandronate sodium hydrate
pharmaceutical raw material
(R)-Omeprazole sodium
pharmaceutical raw material
(R)-Rabeprazole sodium
pharmaceutical raw material
Rabeprazole sodium monohydrate
pharmaceutical raw material
WHCXDEORRDVLKS-UHFFFAOYSA-N
COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC.[Na]
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.